Company intelligence
MedAccess
Accelerating access to medical innovations
About MedAccess
We are a social enterprise committed to improving health in more than 115 countries. Our mission is to cut illness and death by speeding up access to lifesaving vaccines, medicines, diagnostics and technologies for people in underserved communities. Using $170 million capital from British International Investment, our agile team of global health and investment experts shapes agreements that break down the barriers preventing people from accessing medical innovations. We are independent and not-for-profit, with any operating surpluses invested into developing new agreements to accelerate access to healthcare.
Verified activity
Signals from MedAccess
4 published signals
Presence & Recognition
MedAccess Board Chair Professor Helen Rees received the Lifetime Achievement Award at the 2026 The National Research Foundation of South Africa (NRF) Awards.
Reported by MedAccess
Research & Knowledge
MedAccess used GALENOS_Global, a continuously updated global evidence synthesis, to compare the benefits of antipsychotic treatments and re-examine the evidence through country-specific insights from Ethiopia, Nigeria, Rwanda, and South Africa.
Reported by MedAccess
Partnerships
MedAccess brought together mental health clinicians, policy experts, researchers, and people with lived experience in partnership with the Oxford Precision Psychiatry Lab to explore improving access to mental health treatments in low-resource settings.
Reported by MedAccess
Partnerships
MedAccess partnered with IVCC and BASF to protect millions of lives by accelerating access to next-generation dual-action mosquito nets.
Reported by Michael Anderson CB